Westfield, IN, United States of America

Delu Jiang


Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Carmel, IN (US) (2009)
  • Westfield, IN (US) (2008 - 2012)

Company Filing History:


Years Active: 2008-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Delu Jiang: Pioneering Innovator in Cancer Treatment

Introduction: Delu Jiang is a distinguished inventor hailing from Westfield, IN, with a notable portfolio of four patents under his belt. His groundbreaking work revolves around the development of triazolyl aminopyrimidine compounds for the treatment of cancer, showcasing his commitment to advancing medical science.

Latest Patents: Delu Jiang's latest patents center around triazolyl aminopyrimidine compounds that exhibit significant potential in the fight against cancer. These compounds hold promise in revolutionizing cancer treatment by offering novel therapeutic approaches to combat this widespread disease.

Career Highlights: Currently affiliated with Eli Lilly and Company, a renowned pharmaceutical giant, Delu Jiang has made significant strides in his career as an inventor. His contributions in the field of oncology have garnered recognition for their innovative nature and potential impact on patient care.

Collaborations: Throughout his career, Delu Jiang has collaborated with esteemed professionals in the industry, including coworkers such as Joyce Z Crich and Hong-Yu Li. These collaborations have enriched his research endeavors and fostered a dynamic environment for innovation within the realm of cancer treatment.

Conclusion: Delu Jiang's inventive spirit and dedication to advancing cancer therapeutics through his pioneering work with triazolyl aminopyrimidine compounds exemplify his remarkable contributions to the field of medicine. With a promising trajectory ahead, Delu Jiang continues to inspire with his relentless pursuit of innovative solutions for the benefit of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…